119-hr1349

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1349 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 1349

 To amend title XI of the Social Security Act to exclude providers of 
 certain abortion services from participation in the Medicare program.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 February 13, 2025

Mr. Steube (for himself, Ms. Tenney, Mr. Haridopolos, Mr. McGuire, and 
Mr. Biggs of Arizona) introduced the following bill; which was referred 
to the Committee on Ways and Means, and in addition to the Committee on 
Energy and Commerce, for a period to be subsequently determined by the 
 Speaker, in each case for consideration of such provisions as fall 
 within the jurisdiction of the committee concerned

_______________________________________________________________________

 A BILL

 To amend title XI of the Social Security Act to exclude providers of 
 certain abortion services from participation in the Medicare program.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Women's Protection in Telehealth 
Act''.

SEC. 2. EXCLUDING PROVIDERS OF CERTAIN ABORTION SERVICES FROM 
 PARTICIPATION IN THE MEDICARE PROGRAM.

 

Section 1128 of the Social Security Act (42 U.S.C. 1320a-7) is 
amended--

    (1) in subsection

    (a) --
        (A) in the matter preceding paragraph

    (1) , by 
 inserting ``(or, in the case of individuals and 
 entities described in paragraph

    (5) , from participation 
 in the Medicare program under title XVIII)'' after 
 ``(as defined in 

section 1128B

    (f) )''; and
        (B) by inserting after paragraph

    (4) the following 
 new paragraph:
 ``

    (5) Provision of abortion-inducing drugs.--Any individual 
 or entity that, on or after the date of the enactment of this 
 paragraph, prescribes, administers, dispenses, or furnishes an 
 abortion-inducing drug to a patient, unless such individual or 
 entity--
 ``
        (A) is a physician;
 ``
        (B) physically examines the patient;
 ``
            (C) is physically present in the same room with 
 the patient at the time the patient is administered, 
 takes, or uses (as applicable) such drug; and
 ``
            (D) schedules an in-person follow-up visit for 
 the patient to occur not more than 14 days after the 
 patient is administered, takes, or uses (as applicable) 
 such drug.''; and

    (2) in subsection
            (c) (3) --
        (A) in subparagraph
        (A) , by striking ``subsection

    (b)

    (12) '' and inserting ``subsection

    (a)

    (5) or

    (b)

    (12) '';
        (B) in subparagraph
        (B) , by striking ``subparagraph
        (G) '' and inserting ``subparagraphs
        (G) and
        (H) '';
            (C) in subparagraph
        (G) , by inserting ``(other than 
 under paragraph

    (5) of such subsection)'' after 
 ``subsection

    (a) ''; and
            (D) by adding at the end the following new 
 subparagraph:
 ``
        (H) In the case of an exclusion under subsection

    (a)

    (5) , the 
exclusion shall be permanent.'';

    (3) in subsection
            (d) , by adding at the end the following 
 new paragraph:
 ``

    (4) The provisions of this subsection shall not apply in the case 
of an exclusion under subsection

    (a)

    (5) .'';

    (4) in subsection

    (g) , by adding at the end the following 
 new paragraph:
 ``

    (4) The provisions of this subsection shall not apply in the case 
of an exclusion under subsection

    (a)

    (5) .''; and

    (5) by adding at the end the following new subsection:
 ``

    (k) Abortion-Inducing Drug Defined.--
 ``

    (1) In general.--For purposes of subsection

    (a) , the term 
 `abortion-inducing drug' means any medicine, drug, or any other 
 substance that is prescribed, administered, dispensed, or 
 furnished with the intent of terminating the clinically 
 diagnosable pregnancy of a woman and with knowledge that the 
 termination will with reasonable likelihood cause the death of 
 the unborn child (including the off-label use of any such 
 drug).
 ``

    (2) Unborn child.--The term `unborn child' has the 
 meaning given such term in 

section 1841 of title 18, United 
 States Code.''.
 <all>